Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Mylan Inc       US6285301072

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2015 9 703 M
EBIT 2015 2 653 M
Net income 2015 1 975 M
Debt 2015 7 187 M
Yield 2015 -
Sales 2016 10 361 M
EBIT 2016 3 180 M
Net income 2016 2 341 M
Debt 2016 5 510 M
Yield 2016 -
PER 2015 25,86
PER 2016 18,09
EV / Sales 2015 4,28x
EV / Sales 2016 3,85x
Capitalization 34 361 M
More Financials
Company
Mylan N.V., is a pharmaceutical company which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceutical products.It operates through the following businesses: Generic Products, Rx Products, Active Pharmaceutical Ingredients, and Access... 
Sector
Pharmaceuticals
Calendar
07/29Earnings Release
More about the company
Surperformance© ratings of Mylan Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on MYLAN INC
06/29 Second-quarter M&A close to record amid mega deals
06/22 EXCLUSIVE : CVC and Temasek to buy $2 billion generic drugs firm Alvogen
06/22 CVC and Temasek to buy $2 billion generic drugs firm Alvogen
06/19DJTeva Takes 4.6% Stake in Mylan
06/19DJTeva Takes 4.6% Stake in Mylan
06/18DJTeva's Copaxone Patent Again Struck Down by U.S. Court -- 2nd Update
06/18DJTeva's Copaxone Patent Again Struck Down by U.S. Court -- Update
06/18DJTeva's Copaxone Patent Loses Again
More news
Sector news : Pharmaceuticals - NEC
01:00a OPKO HEALTH : and Bio-Reference Laboratories Announce Early Termination of the W..
07/03 Exclusive - Hospira wins French biosimilar drug tender at 45 percent discount
07/03 MALLINCKRODT : takes on FDA in fight over ADHD generic
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
03/02 Mylan (MYL) Heather M. Bresch on Q4 2014 Results - Earnings Call Transcript
03/02 Mylan Q4 revenues up 15%, Specialty up 38%
03/02 Mylan (MYL) Q4 2014 Results - Earnings Call Webcast
03/02 Mylan EPS in-line, beats on revenue
03/01 Notable earnings after Monday?s close
Comments 
Advertisement
Chart MYLAN INC
Duration : Period :
Mylan Inc Technical Analysis Chart | US6285301072 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions